What Happened?
San Francisco, CA-based Pionyr-Immunotherapeutics Appointed Steven James as Chief Executive Officer
About the Company
Pionyr Immuntherapeutics (formerly Precision Immune Inc.) is developing cancer immunotherapies that target the tumor microenvironment to enhance the body`s antitumor immunity. The company is exploiting novel target discovery and antibody generation platform technologies to create the next generation of immuno-oncology therapeutics. The company`s approach, Myeloid Tuning™, is designed to enhance the immune system`s anti-tumor response by altering the cellular infiltrate of the tumor microenvironment with high specificity.
About the Person
Steven James is Chief Executive Officer at Pionyr Immunotherapeutics. Previously, Steven held various senior HR leadership roles in the industry.
Info Source
News
Short Profile